Literature DB >> 32509832

The future of adjuvant therapy in ampullary cancer: should we offer it to our patients?

Sri Harsha Tella1, Amit Mahipal2.   

Abstract

Entities:  

Year:  2020        PMID： 32509832      PMCID： PMC7262616          DOI： 10.21037/hbsn.2019.11.06

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  2 in total

Review 1.  Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: A systematic review.

Authors:  Zhiqing Duan; Yinuo Zhang; Yajie Tang; Ruqing Gao; Jing Bao; Bo Liang
Journal:  Transl Oncol       Date:  2022-04-06       Impact factor: 4.243

2.  Remission from the 5-Fu-Based Chemotherapy to Gemcitabine-Based Chemotherapy-Based on the Pathological Classification of Periampullary Carcinoma: A Case Report and Literature Review.

Authors:  Wei Hu; Zhiqing Duan; Yinuo Zhang; Jing Liu; Jing Bao; Ruqing Gao; Yajie Tang; Tiande Liu; Hu Xiong; Wen Li; Xiaowei Fu; Shousheng Liao; Lu Fang; Bo Liang
Journal:  Onco Targets Ther       Date:  2022-08-25       Impact factor: 4.345
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.